Biogen, Inc. (BIIB)
250.48
-2.92
(-1.15%)
USD |
NASDAQ |
Nov 12, 16:00
250.69
+0.21
(+0.08%)
After-Hours: 20:00
Biogen Market Cap : 37.02B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 37.02B |
| November 11, 2026 | 37.45B |
| November 10, 2026 | 37.43B |
| November 09, 2026 | 37.67B |
| November 06, 2026 | 36.71B |
| November 05, 2026 | 36.05B |
| November 04, 2026 | 37.61B |
| November 03, 2026 | 36.79B |
| November 02, 2026 | 36.80B |
| October 30, 2026 | 37.49B |
| October 29, 2026 | 36.90B |
| October 28, 2026 | 36.07B |
| October 27, 2026 | 37.35B |
| October 26, 2026 | 37.28B |
| October 23, 2026 | 37.05B |
| October 22, 2026 | 37.49B |
| October 21, 2026 | 35.59B |
| October 20, 2026 | 35.91B |
| October 19, 2026 | 34.48B |
| October 16, 2026 | 34.36B |
| October 15, 2026 | 34.76B |
| October 14, 2026 | 34.39B |
| October 13, 2026 | 33.81B |
| October 12, 2026 | 33.88B |
| October 09, 2026 | 33.34B |
| Date | Value |
|---|---|
| October 08, 2026 | 32.26B |
| October 07, 2026 | 32.81B |
| October 06, 2026 | 32.92B |
| October 05, 2026 | 33.02B |
| October 02, 2026 | 32.48B |
| October 01, 2026 | 32.91B |
| September 30, 2026 | 33.36B |
| September 29, 2026 | 33.54B |
| September 28, 2026 | 33.78B |
| September 25, 2026 | 33.62B |
| September 24, 2026 | 33.43B |
| September 23, 2026 | 33.61B |
| September 22, 2026 | 33.29B |
| September 21, 2026 | 32.36B |
| September 18, 2026 | 31.83B |
| September 17, 2026 | 32.35B |
| September 16, 2026 | 31.90B |
| September 15, 2026 | 31.93B |
| September 14, 2026 | 32.10B |
| September 11, 2026 | 32.07B |
| September 10, 2026 | 31.82B |
| September 09, 2026 | 31.12B |
| September 08, 2026 | 31.39B |
| September 04, 2026 | 32.62B |
| September 03, 2026 | 33.16B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 520.44B |
| Gilead Sciences, Inc. | 208.43B |
| Amgen, Inc. | 252.63B |
| Regeneron Pharmaceuticals, Inc. | 98.35B |
| Eli Lilly & Co. | 1.343T |
Market Cap Related Metrics
| PE Ratio | 107.23 |
| PS Ratio | 3.743 |
| Price to Book Value | 1.956 |
| Price to Free Cash Flow | 22.53 |
| Price | 250.48 |
| Earnings Yield | 0.93% |
| Operating PE Ratio | 21.62 |
| Normalized PE Ratio | 32.48 |